메뉴 건너뛰기




Volumn 13, Issue , 2013, Pages

The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

Author keywords

Gastric cancer; Polymorphism; VEGF

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; GENOMIC DNA; OXALIPLATIN; VASCULOTROPIN;

EID: 84873038775     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-43     Document Type: Article
Times cited : (30)

References (31)
  • 1
    • 14944385553 scopus 로고    scopus 로고
    • Global cancer statistics
    • 10.3322/canjclin.55.2.74, 15761078
    • Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
    • (2005) CA Cancer J Clin , vol.55 , Issue.2 , pp. 74-108
    • Parkin, D.M.1    Bray, F.2    Ferlay, J.3    Pisani, P.4
  • 2
    • 79958814789 scopus 로고    scopus 로고
    • Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008
    • 10.4143/crt.2011.43.1.1, 3072529, 21509157
    • Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011, 43(1):1-11. 10.4143/crt.2011.43.1.1, 3072529, 21509157.
    • (2011) Cancer Res Treat , vol.43 , Issue.1 , pp. 1-11
    • Jung, K.W.1    Park, S.2    Kong, H.J.3
  • 3
    • 33745547767 scopus 로고    scopus 로고
    • Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data
    • 10.1200/JCO.2005.05.0245, 16782930
    • Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006, 24(18):2903-2909. 10.1200/JCO.2005.05.0245, 16782930.
    • (2006) J Clin Oncol , vol.24 , Issue.18 , pp. 2903-2909
    • Wagner, A.D.1    Grothe, W.2    Haerting, J.3    Kleber, G.4    Grothey, A.5    Fleig, W.E.6
  • 4
    • 80054717683 scopus 로고    scopus 로고
    • The role of chemotherapy in metastatic gastric cancer
    • Pasini F, Fraccon AP, DEM G. The role of chemotherapy in metastatic gastric cancer. Anticancer Res 2011, 31(10):3543-3554.
    • (2011) Anticancer Res , vol.31 , Issue.10 , pp. 3543-3554
    • Pasini, F.1    Fraccon, A.P.2    Dem, G.3
  • 5
    • 34247326603 scopus 로고    scopus 로고
    • A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer
    • 10.1080/02841860600791483, 17450469
    • Oh SY, Kwon HC, Seo BG, Kim SH, Kim JS, Kim HJ. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer. Acta Oncol 2007, 46(3):336-341. 10.1080/02841860600791483, 17450469.
    • (2007) Acta Oncol , vol.46 , Issue.3 , pp. 336-341
    • Oh, S.Y.1    Kwon, H.C.2    Seo, B.G.3    Kim, S.H.4    Kim, J.S.5    Kim, H.J.6
  • 6
    • 79952407394 scopus 로고    scopus 로고
    • Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer
    • 10.4143/crt.2010.42.1.24, 2848744, 20369048
    • Kim YS, Hong J, Sym SJ, et al. Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer. Cancer Res Treat 2010, 42(1):24-29. 10.4143/crt.2010.42.1.24, 2848744, 20369048.
    • (2010) Cancer Res Treat , vol.42 , Issue.1 , pp. 24-29
    • Kim, Y.S.1    Hong, J.2    Sym, S.J.3
  • 7
    • 0031039243 scopus 로고    scopus 로고
    • The biology of vascular endothelial growth factor
    • 10.1210/er.18.1.4, 9034784
    • Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18(1):4-25. 10.1210/er.18.1.4, 9034784.
    • (1997) Endocr Rev , vol.18 , Issue.1 , pp. 4-25
    • Ferrara, N.1    Davis-Smyth, T.2
  • 8
    • 0031037638 scopus 로고    scopus 로고
    • Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma
    • Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 1997, 15(2):826-832.
    • (1997) J Clin Oncol , vol.15 , Issue.2 , pp. 826-832
    • Tanigawa, N.1    Amaya, H.2    Matsumura, M.3    Shimomatsuya, T.4
  • 9
    • 0030066037 scopus 로고    scopus 로고
    • Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
    • 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A, 8608475
    • Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996, 77(5):858-863. 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A, 8608475.
    • (1996) Cancer , vol.77 , Issue.5 , pp. 858-863
    • Maeda, K.1    Chung, Y.S.2    Ogawa, Y.3
  • 10
    • 0033865580 scopus 로고    scopus 로고
    • Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production
    • 10.1006/cyto.2000.0692, 10930302
    • Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000, 12(8):1232-1235. 10.1006/cyto.2000.0692, 10930302.
    • (2000) Cytokine , vol.12 , Issue.8 , pp. 1232-1235
    • Watson, C.J.1    Webb, N.J.2    Bottomley, M.J.3    Brenchley, P.E.4
  • 11
    • 70349499022 scopus 로고    scopus 로고
    • The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
    • 10.1158/1535-7163.MCT-09-0302, 2751847, 19755511
    • Jain L, Vargo CA, Danesi R, et al. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 2009, 8(9):2496-2508. 10.1158/1535-7163.MCT-09-0302, 2751847, 19755511.
    • (2009) Mol Cancer Ther , vol.8 , Issue.9 , pp. 2496-2508
    • Jain, L.1    Vargo, C.A.2    Danesi, R.3
  • 12
    • 33845226536 scopus 로고    scopus 로고
    • Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival
    • 10.1002/jso.20619, 17111394
    • Tzanakis N, Gazouli M, Rallis G, et al. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 2006, 94(7):624-630. 10.1002/jso.20619, 17111394.
    • (2006) J Surg Oncol , vol.94 , Issue.7 , pp. 624-630
    • Tzanakis, N.1    Gazouli, M.2    Rallis, G.3
  • 13
    • 34447295882 scopus 로고    scopus 로고
    • Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer
    • 10.1093/annonc/mdm085, 17426061
    • Kim JG, Sohn SK, Chae YS, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol 2007, 18(6):1030-1036. 10.1093/annonc/mdm085, 17426061.
    • (2007) Ann Oncol , vol.18 , Issue.6 , pp. 1030-1036
    • Kim, J.G.1    Sohn, S.K.2    Chae, Y.S.3
  • 14
    • 0036984738 scopus 로고    scopus 로고
    • Tumor angiogenesis and accessibility: role of vascular endothelial growth factor
    • Jain RK. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Semin Oncol 2002, 29(6 Suppl 16):3-9.
    • (2002) Semin Oncol , vol.29 , Issue.6 SUPPL. 16 , pp. 3-9
    • Jain, R.K.1
  • 15
    • 79151473796 scopus 로고    scopus 로고
    • The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer
    • 10.1038/tpj.2010.4, 20125120
    • Hansen TF, Garm Spindler KL, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A. The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer. Pharmacogenomics J 2011, 11(1):53-60. 10.1038/tpj.2010.4, 20125120.
    • (2011) Pharmacogenomics J , vol.11 , Issue.1 , pp. 53-60
    • Hansen, T.F.1    Garm Spindler, K.L.2    Andersen, R.F.3    Lindebjerg, J.4    Brandslund, I.5    Jakobsen, A.6
  • 16
    • 79957510326 scopus 로고    scopus 로고
    • VEGF - 460 T C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma
    • 10.1038/tpj.2010.48, 20531372
    • Chen MH, Tzeng CH, Chen PM, et al. VEGF - 460 T C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma. Pharmacogenomics J 2011, 11(3):227-236. 10.1038/tpj.2010.48, 20531372.
    • (2011) Pharmacogenomics J , vol.11 , Issue.3 , pp. 227-236
    • Chen, M.H.1    Tzeng, C.H.2    Chen, P.M.3
  • 17
    • 33847645479 scopus 로고    scopus 로고
    • Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer
    • Kwon HC, Roh MS, Oh SY, et al. Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. Ann Oncol 2007, 18(3):504-509.
    • (2007) Ann Oncol , vol.18 , Issue.3 , pp. 504-509
    • Kwon, H.C.1    Roh, M.S.2    Oh, S.Y.3
  • 18
    • 68249140418 scopus 로고    scopus 로고
    • Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI
    • Seo BG, Kwon HC, Oh SY. Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI. Oncol Rep 2009, 22(1):127-136.
    • (2009) Oncol Rep , vol.22 , Issue.1 , pp. 127-136
    • Seo, B.G.1    Kwon, H.C.2    Oh, S.Y.3
  • 19
    • 0035187771 scopus 로고    scopus 로고
    • Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications
    • 10.1016/S1470-2045(01)00556-3, 11902537
    • Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2001, 2(11):667-673. 10.1016/S1470-2045(01)00556-3, 11902537.
    • (2001) Lancet Oncol , vol.2 , Issue.11 , pp. 667-673
    • Toi, M.1    Matsumoto, T.2    Bando, H.3
  • 20
    • 58149346076 scopus 로고    scopus 로고
    • Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab
    • 10.1158/1078-0432.CCR-08-0351, 2586993, 19010874
    • Schultheis AM, Lurje G, Rhodes KE, et al. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res 2008, 14(22):7554-7563. 10.1158/1078-0432.CCR-08-0351, 2586993, 19010874.
    • (2008) Clin Cancer Res , vol.14 , Issue.22 , pp. 7554-7563
    • Schultheis, A.M.1    Lurje, G.2    Rhodes, K.E.3
  • 21
    • 53749093040 scopus 로고    scopus 로고
    • Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100
    • 10.1200/JCO.2008.16.1612, 2653128, 18824714
    • Schneider BP, Wang M, Radovich M, et al. Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol 2008, 26(28):4672-4678. 10.1200/JCO.2008.16.1612, 2653128, 18824714.
    • (2008) J Clin Oncol , vol.26 , Issue.28 , pp. 4672-4678
    • Schneider, B.P.1    Wang, M.2    Radovich, M.3
  • 22
    • 79951723590 scopus 로고    scopus 로고
    • Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab
    • 10.1007/s00384-010-1108-1, 21188390
    • Formica V, Palmirotta R, Del Monte G, et al. Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab. Int J Colorectal Dis 2011, 26(2):143-151. 10.1007/s00384-010-1108-1, 21188390.
    • (2011) Int J Colorectal Dis , vol.26 , Issue.2 , pp. 143-151
    • Formica, V.1    Palmirotta, R.2    Del Monte, G.3
  • 23
    • 46849098774 scopus 로고    scopus 로고
    • Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer
    • 10.3346/jkms.2008.23.3.421, 2526538, 18583877
    • Chae YS, Kim JG, Sohn SK, et al. Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci 2008, 23(3):421-427. 10.3346/jkms.2008.23.3.421, 2526538, 18583877.
    • (2008) J Korean Med Sci , vol.23 , Issue.3 , pp. 421-427
    • Chae, Y.S.1    Kim, J.G.2    Sohn, S.K.3
  • 24
    • 34547770379 scopus 로고    scopus 로고
    • Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer
    • Park HM, Hong SH, Kim JW, et al. Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer. Anticancer Res 2007, 27(4B):2535-2539.
    • (2007) Anticancer Res , vol.27 , Issue.4 B , pp. 2535-2539
    • Park, H.M.1    Hong, S.H.2    Kim, J.W.3
  • 25
    • 42549161440 scopus 로고    scopus 로고
    • Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C > T) gene and colon cancer in Korea
    • Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C > T) gene and colon cancer in Korea. Anticancer Res 2008, 28(2B):1271-1276.
    • (2008) Anticancer Res , vol.28 , Issue.2 B , pp. 1271-1276
    • Bae, S.J.1    Kim, J.W.2    Kang, H.3    Hwang, S.G.4    Oh, D.5    Kim, N.K.6
  • 26
    • 38449109288 scopus 로고    scopus 로고
    • Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer
    • Fukuda H, Tsuchiya N, Narita S, et al. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer. Oncol Rep 2007, 18(5):1155-1163.
    • (2007) Oncol Rep , vol.18 , Issue.5 , pp. 1155-1163
    • Fukuda, H.1    Tsuchiya, N.2    Narita, S.3
  • 27
    • 40749139487 scopus 로고    scopus 로고
    • Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer
    • 10.1158/1078-0432.CCR-07-1537, 18172253
    • Kim JG, Chae YS, Sohn SK, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 2008, 14(1):62-66. 10.1158/1078-0432.CCR-07-1537, 18172253.
    • (2008) Clin Cancer Res , vol.14 , Issue.1 , pp. 62-66
    • Kim, J.G.1    Chae, Y.S.2    Sohn, S.K.3
  • 28
    • 0035208145 scopus 로고    scopus 로고
    • New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation
    • 10.1210/me.15.12.2197, 11731620
    • Huez I, Bornes S, Bresson D, Creancier L, Prats H. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 2001, 15(12):2197-2210. 10.1210/me.15.12.2197, 11731620.
    • (2001) Mol Endocrinol , vol.15 , Issue.12 , pp. 2197-2210
    • Huez, I.1    Bornes, S.2    Bresson, D.3    Creancier, L.4    Prats, H.5
  • 29
    • 0036316846 scopus 로고    scopus 로고
    • A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes
    • 10.2337/diabetes.51.5.1635, 11978667
    • Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002, 51(5):1635-1639. 10.2337/diabetes.51.5.1635, 11978667.
    • (2002) Diabetes , vol.51 , Issue.5 , pp. 1635-1639
    • Awata, T.1    Inoue, K.2    Kurihara, S.3
  • 30
    • 77953348691 scopus 로고    scopus 로고
    • A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer
    • Kim BG, Oh SY, Kwon HC, et al. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer. Am J Clin Oncol 2010, 33(3):246-250.
    • (2010) Am J Clin Oncol , vol.33 , Issue.3 , pp. 246-250
    • Kim, B.G.1    Oh, S.Y.2    Kwon, H.C.3
  • 31
    • 77949414964 scopus 로고    scopus 로고
    • Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer
    • 10.1002/cncr.24925, 20108336
    • Overman MJ, Kazmi SM, Jhamb J, et al. Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer. Cancer 2010, 116(6):1446-1453. 10.1002/cncr.24925, 20108336.
    • (2010) Cancer , vol.116 , Issue.6 , pp. 1446-1453
    • Overman, M.J.1    Kazmi, S.M.2    Jhamb, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.